for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

BRIEF-Karyopharm Therapeutics Posts Q4 Loss Per Share Of $0.76

Feb 13 (Reuters) - Karyopharm Therapeutics Inc:

* KARYOPHARM REPORTS FOURTH QUARTER AND FULL YEAR 2019 FINANCIAL RESULTS AND HIGHLIGHTS RECENT COMPANY PROGRESS

* Q4 LOSS PER SHARE $0.76

* Q4 EARNINGS PER SHARE ESTIMATE $-0.67 -- REFINITIV IBES DATA

* QTRLY TOTAL REVENUES $18.1 MILLION VERSUS $206,000 Source text for Eikon: Further company coverage:

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up